- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
e
ENGNW
enGene Therapeutics Inc
0.2340
-0.0011-0.47%Closed14:42 05/22 EDT
OPEN/PREV CLOSE0.2350/0.2351
TODAY RANGE0.2340-0.2351
VOL4.87K
MARKET CAP--
52 WEEK RANGE0.1113-4.200
AVG VOL (3M)13.42K
% TURNOVER0%
TURNOVER--
P/E (TTM)-0.1039
% RANGE0.47%
EPS(TTM)-2.2529
P/E(FORWARD)--
P/B0.0557
BVPS4.203
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP--
SHARES OUTSTANDING--
NEXT EARNINGS03/09-03/13
FREE FLOAT--
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·05/14 21:41
enGene Holdings Is Maintained at Neutral by UBS
Dow Jones·05/14 21:41
enGene Holdings Price Target Cut to $2.00/Share From $9.00 by UBS
TipRanks·05/14 15:24
enGene price target lowered to $2 from $9 at UBS
Reuters·05/14 12:14
ENGENE THERAPEUTICS INC <ENGN.O>: UBS CUTS TARGET PRICE TO $2 FROM $9
PUBT·05/08 20:08
enGene Therapeutics announces annual shareholder meeting webcast
TipRanks·05/08 18:32
Leerink downgraded enGene to Market Perform following LEGEND update
TipRanks·05/08 16:22
enGene downgraded to Perform from Outperform at Oppenheimer
Benzinga·05/08 15:34
Why Is enGene Therapeutics Stock Falling Friday?
Dow Jones·05/08 14:56
enGene Holdings Cut to Market Perform From Market Outperform by Citizens
Benzinga·05/08 14:46
Citizens Downgrades enGene Therapeutics to Market Perform
Dow Jones·05/08 13:01
enGene Holdings Cut to Neutral From Buy by Guggenheim
Benzinga·05/08 12:51
Guggenheim Downgrades enGene Therapeutics to Neutral
Dow Jones·05/08 12:38
enGene Holdings Cut to Equal-Weight From Overweight by Wells Fargo
Dow Jones·05/08 12:38
enGene Holdings Price Target Cut to $2.00/Share From $25.00 by Wells Fargo